cardio-met Profile picture
Apr 20 36 tweets 43 min read
1) Welcome to our #accredited #tweetorial on optimal mgt of #hyperkalemia in the patient with #CKD. Earn 0.5h #CME/CE credit by following this thread. I am Sourabh Sharma MD DNB FASN 🇮🇳 @iamnephrologist & u have found the ONLY source for CE credit delivered entirely on Twitter!
2) This program is supported by educational grants from AstraZeneca, Bayer, & Chiesi & is intended for #healthcare providers. See faculty disclosures cardiometabolic-ce.com/disclosures/. Educational credit for #physicians #physicianassociate #nurses #nursepractitioners #pharmacists 🇺🇸🇨🇦🇪🇺🇬🇧
3) Potassium first isolated by Humphry Davy in 1807 by electrolysis (Coined word from “Potash” [Dutch]). The periodic table symbol K was derived from kali (alkali) [Arabic].
en.wikipedia.org/wiki/Potassium
#NephroNotes #NephPearls #FOAMed #MedEd @MedTweetorials #CardioTwitter
4) Re potassium #homeostasis: 98% of the body's K lies in intracellular space➡️ helping determine resting membrane potential & intracellular electronegativity.
10% of K secretion is via the colon (↑significantly in advancing CKD) 🔓kidney360.asnjournals.org/content/1/1/65 #NephroNotes
5) There is debate abt the definition of hyperK (>5? >5.5?), but it is classified by serum K & ECG. Mortality risk is independent of symptoms, but not ECG findings, as bradycardia/junctional rhythm/QRS widening→Poor outcome.
🔓kidney-international.org/article/S0085-…
🔓mayoclinicproceedings.org/article/S0025-…
6) Arrhythmia in Hyperkalemia
Moderate HyperK: Fast Na channel activation; ↑excitability/conduction velocity: Peaked T
Severe HyperK: Fast Na channel inactivation/Inwardly rectifying K channel activation: Wide QRS/Conduction block
🔓academic.oup.com/ndt/article/34…
7) There are multiple causes of #hyperkalemia:
a. Pseudohyperkalemia
b. Redistribution
c. Excess intake
d. Impaired renal K secretion
In #CKD, relative risk of hyperK approximately doubles for every⬇️in eGFR of 15 mL/min
🔓ccjm.org/content/84/12/…
#NephroNotes #NephPearls #MedEd
8) Because it may be unexpected, we must be especially cautious of drug-induced hyperkalemia
🔓academic.oup.com/ndt/article/34…
#NephroNotes #NephPearls #FOAMed #MedEd
9) So let's focus on #hyperkalemia in #CKD ➡️adverse outcomes, as it restricts RAASi & MRA usage. #CKD patients have multiple risk factors for hyperkalemia. For those on dialysis, long interdialytic gap ↑hyperkalemia chances
nature.com/articles/nrnep…
#NephroNotes #NephPearls
10) This table is a nice summary of causes and treatment of hyperkalemia across continuum of kidney function, from 🔓cjasn.asnjournals.org/content/13/1/1…
#NephroNotes #NephPearls #FOAMed #MedEd
11) A low-K diet is generally recommended in advanced #CKD, but @goKDIGO suggests interventional trials to determine optimal recommendations, as there is no direct evidence to link dietary K & serum K, and the benefits of K can’t be ignored
🔓kidney360.asnjournals.org/content/1/1/65
#NephroNotes
12) Guidelines for use of #RAAS inhibitors are intertwined with K homeostasis. Strive for maximum tolerated RAASi therapy! Treat hyperkalemia & reinitiate RAASi after resolution, then reassess K level within 1 wk
🔓ccjm.org/content/84/12/…
🔓mayoclinicproceedings.org/article/S0025-…
#NephPearls
13) Patient education is🔑:
@NKF recommends⬆️patient awareness of hyperK
👉Educational tools
👉Lifestyle change
👉Dietary modification
👉Campaigns
👉Involve allied healthcare professionals
Hyperkalemia is often asymptomatic; regular K monitoring needed!🔓kidney.org/atoz/content/h…
14) The National Institute for Health and Care Excellence #NICE offers a systematic Treatment Approach to #hyperkalemia
👉Account for clinical priorities
👉↓variability
👉↑patient outcome
👉↓adverse events
🔓ukkidney.org/sites/renal.or…
#NephroNotes #NephPearls #FOAMed #MedEd
15) So when hyperK happens, how is it treated? Acutely:
👉IV calcium ↓cardiac membrane excitation (1-3 min)
👉Insulin/glucose & β agonist redistribute K to ICS (30-60 min) but not ↓total body K
👉β Agonists: short duration of effect (2-4hrs)
👉Sodium bicarbonate ↑K elimination
16) #Hemodialysis increases total K elimination & is used for resistant acute hyperkalemia
🔓mayoclinicproceedings.org/article/S0025-…
#NephroNotes #NephPearls #FOAMed #MedEd
17) So among acute treatment options, different medications have rapid, intermediate or delayed onset of action
Rapidly & intermediately acting medications are required in acute hyperkalemia management
🔓pubmed.ncbi.nlm.nih.gov/23882341/
#NephroNotes #NephPearls #FOAMed #MedEd
18) So let's look at drug administration & safety of different emergency use medications
IV Calcium preparation
👉Calcium Chloride
👉Calcium Gluconate
🔓ukkidney.org/sites/renal.or…
#NephroNotes #NephPearls
19) Insulin/Glucose Infusion: Consider
👉Drug administration & safety
👉Alternative glucose preparations
🔓ukkidney.org/sites/renal.or…
#NephroNotes #NephPearls #FOAMed #MedEd
20) #Salbutamol: Drug administration & safety
Effective but more likely to produce side effects
🔓ukkidney.org/sites/renal.or…
#NephroNotes #NephPearls #FOAMed #MedEd
21) So now let's look at oral potassium binders, which are more useful in chronic mgt & can help facilitate #RAASi optimization. Which of the following binders has the most rapid onset of action after oral administration?
22) Mark your best response & return TOMORROW for the correct answer and the remainder of this program! 👏to @sibgokcay @dr_nikhilshah @kdjhaveri @proychaudhuryMD @divyaa24 @arvindcanchi @priti899 @vjha126 @nephprasad @Gawad_Nephro @SmeetaSinha @Priyasinghbmc @Joe_Vassalotti
23) Welcome back! I am @iamnephrologist and we're talking about #hyperkalemia in #CKD and what to do about it! You are earning🆓CE/#CME, #physicians #physicianassistants #nursepractitioners #pharmacists #nurses. Shout-outs to @vipvargh @gudnephron @SwastiThinks @docanjuyadav
24) We were about to start talking about the oral K binders. (BTW earn MORE CE/#CME on this topic at cardiometabolic-ce.com/category/hyper…) Yes, prune juice is a K binder, but it's not quick, and it may make a bigger mess than Na polystyrene sulfonate. So the correct answer was D.
25) So these oral potassium binders are to be considered in chronic #hyperkalemia despite diuretic therapy/corrected metabolic acidosis. They potentially allow continuation/optimization of RAASi/ MRA
🔓mayoclinicproceedings.org/article/S0025-…
#NephroNotes #NephPearls #FOAMed #MedEd
26) So in the K binder🌎, there is old and there is new.
New binders have opened new horizons for treatment & prevention of hyperkalemia
🔓ukkidney.org/sites/renal.or…
#NephroNotes #NephPearls #FOAMed #MedEd
27) Start w/the old. Sodium/Calcium Polysterene Sulfonate clinical studies:
👉Limited evidence for effectiveness/safety
👉With sorbitol, can cause colonic necrosis
👉Nonselective for K, with affinity for Ca/Mg ions
👉Caution: Na & volume overload
🔓frontiersin.org/articles/10.33…
28) And then the new. First, #patiromer sorbitex calcium clinical studies:
👉Efficacy established in randomized, placebo-controlled, phase 2 and 3 trials (CKD/ HF/RAASi)
👉Onset of action~ 7 hours
👉No serious AEs
🔓frontiersin.org/articles/10.33…
#NephPearls #FOAMed #MedEd
29) Sodium Zirconium Cyclosilicate (#SZC) clinical studies:
👉Efficacy & safety established in Ph 2 & 3 trials (#CKD/#HF/#DM/#RAASi)
👉assoc'd w/ ↑Bicarbonate
👉High selectivity for K & ammonium ions
👉fast onset, starts in small bowel
👉No serious AEs
🔓frontiersin.org/articles/10.33…
30) Summary: Clinical trials of oral potassium binders
🔓ukkidney.org/sites/renal.or…
#NephroNotes #NephPearls #FOAMed #MedEd
31) Treatment of #Hyperkalemia in #hemodialysis patients:
👉Hyperkalaemia contributes to mortality in HD (3-5% deaths)
👉K ⤴️is most common immediately post 3-day weekend break
👉Adjust dialysate K as per 🔓ukkidney.org/sites/renal.or…
32) In summary, the treatment of hyperkalemia is likely to evolve in the coming years with the availability of novel drugs & the development of new strategies to improve safety. Clinical decisions on when to treat & how aggressively to treat require a pt-centered approach ...
33) ... guided by the clinical setting and rate of change in serum K+ level. Patients with moderate levels of hyperkalemia pose the greatest dilemma, especially when acuity is low, but warrant intervention to avoid deterioration.
34) Severe hyperkalemia risks arrhythmias & cardiac arrest, therefore prompt recognition and intervention is required. How big a problem is it? In-hospital mortality is significantly higher in patients w/ hyperkalaemia (X%) hypokalaemia (Y%) vs normokalaemia (Z%). What are X,Y,Z?
35) Per NICE guidelines, the correct answer is B, more exactly hyperkalemia (18.1%) compared to those with hypokalemia (5.0%) or normokalemia (3.9%). Pts with severe hyperK (> 6.5 mmol/l) are most at risk & in one report (🔓pubmed.ncbi.nlm.nih.gov/23171442/), hospital mortality was 30.7%.
36) And that's it! You made it! Go grab your CE/#CME certificate at cardiometabolic-ce.com/hyperk5/. I am @iamnephrologist and I hope you'll FOLLOW @cardiomet_ce AND @ckd_ce for more #accredited #tweetorials from expert authors all over the 🌎🌍🌏!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with cardio-met

cardio-met Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @cardiomet_CE

Apr 5
9) Many risk factors modulate the propensity of LDL-C to traverse the endothelium and enter the arterial intima. See 🔓academic.oup.com/eurheartj/arti….
10) It now appears that the passage of #LDL into the #intima is not a merely passive process whereby the concentration in blood & the permeability of the endothelium determine LDL accumulation.
11) It’s #Transcytosis (an active process), through a vesicular pathway involving #caveolae, scavenger receptors (#SRB1) and activin like receptor kinase 1 (#ALK1). Hence for a given blood level of LDL-C the amount of atherosclerosis is variable.
Read 36 tweets
Apr 5
1) Welcome to an #accredited #tweetorial on the role of ⬆️ #LDL-C levels in the pathogenesis & pathophysiology of #ASCVD. I am Kausik Ray MD FRCP @profkausikray, Professor of Public Health & Cardiologist @imperialcollege London AND President of European Atherosclerosis Society
2) This #tweetorial, accredited for #CME/CE and intended for #physicians #physicianassociates #nurses #nursepractitioners #pharmacists is supported by an educational grant from Esperion Therapeutics. See faculty disclosures at cardiometabolic-ce.com/disclosures/.
3) #Atherosclerosis starts in childhood, progresses in fits and spurts and presents in middle to late life in the form of major adverse cardiovascular events #MACE.
Read 4 tweets
Mar 29
1) Welcome to a new #accredited #tweetorial on parenteral #antiplatelet therapy in #neurovascular interventions. Our expert author is Fawaz Al-Mufti MD @almuftifawaz, interventional #neurologist Interventional Neurologist @NYMedcollege @WestchesterMed @neurocritical @svinsociety
2) This program is intended for #healthcare providers & is accredited for 0.5h CE/#CME for #physicians #PhysicianAssociate #nursepractitioner #nurse #pharmacists and is supported by educational grants from AstraZeneca, Bayer, and Chiesi.
3) Be sure to see prior tweetorials on #antiplatelet management, still available for credit, at cardiometabolic-ce.com/category/plate…. Faculty disclosures are listed at cardiometabolic-ce.com/disclosures/.
Read 41 tweets
Mar 22
1) Welcome to @cardiomet_CE's new series on #lipid management! This is a 10-#tweetorial program, all #accredited, that will cover it all. Our first expert author is Paul Thompson MD @PaulDThompsonMD, esteemed #cardiologist from @hartfordhosp @UConn Med & now @MGHHeartHealth ! Image
2) This #tweetorial, accredited for #CME/CE and intended for #physicians #physicianassociates #nurses #nursepractitioners #pharmacists is supported by an educational grant from Esperion Therapeutics. See faculty disclosures at cardiometabolic-ce.com/disclosures/.
3) @PaulDThompsonMD took on education re mechanisms & use of ezetimibe & bempedoic acid. He proposes a case: 45 ♂️ w/history of inferior wall #MI treated with primary angioplasty.
Read 57 tweets
Mar 1
1) Welcome to an #accredited #tweetorial on a unique emerging (in Ph3 now) option for specifically reversing the #antiplatelet effects of #ticagrelor: it's #bentracimab. Expert faculty is antithrombotic agent reversal guru @md_pollack of @UMMCnews, working to create #AHealthierMS
2) This program is intended for #healthcare professionals and is supported by an educational grant from PhaseBio Pharmaceuticals. Faculty disclosures are listed at cardiometabolic-ce.com/disclosures/, and prior programs are available for 🆓CE/#CME credit at cardiometabolic-ce.com.
3) It is an unfortunate fact of life that one cannot prescribe #anticoagulant or #antiplatelet (together, #antithrombotic) therapy without increasing a patient's #bleedingrisk. That is why it should be an individualized risk:benefit decision, ideally . . .
Read 51 tweets
Feb 8
1) Welcome to a new #accredited #tweetorial on managing #VTE at the extremes of weight & renal function. Free CE/#CME credit for following along with expert author @AryaRoopen from King’s Thrombosis Centre at King's College Hospital in London! Only the best for our learners! Image
2) When we think about "special populations" in #VTE, we think weight, age, and #cancer status. @aakonc already addressed the last of those (earn credit still at cardiometabolic-ce.com/antithrombotic…). Learn the rest here! Hello to @ProfMakris @bhwords @MiddeldorpS @fniainle @AliTaherMD
3) This educational program is intended for health care providers & is supported by a grant from Bristol Myers Squibb & its Alliance partner Pfizer, Inc. Faculty disclosures at cardiometabolic-ce.com/disclosures/. Credit for #physicians #physicianassociates #nurses #NPs #pharmacists
Read 51 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(